News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Histogen, Inc. Appoints Scientific Advisory Board Comprised of Regenerative Medicine Leaders



10/12/2011 9:47:09 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held regenerative medicine company, today announced the formation of its Scientific Advisory Board. Histogenics is advancing NeoCart®, an autologous bioengineered neocartilage grown outside the body using the patient’s own cells for the regeneration of cartilage lesions, and VeriCart™, a three-dimensional cartilage matrix to stimulate cartilage repair in a simple, one-step procedure.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES